Helport AI Opens Thailand Office 
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo 
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter 
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future Vertex Energy Announces Third Quarter 2021 Results Conference Call Date
HOUSTON, TX / ACCESSWIRE / November 1, 2021 / Vertex Energy, Inc. (NASDAQ:VTNR) (“Vertex” or…
Envirotech Vehicles Delivers Two Vehicles to Shine Solar, LLC
CORONA, CA / ACCESSWIRE / November 1, 2021 / Envirotech Vehicles, Inc. (OTCQB:ADOM), a provider…
Mexus Announces Revenue For October; Revenues From Gold Sales Expected To Increase
CABORCA, MEXICO / ACCESSWIRE / November 1, 2021 / Mexus Gold US (OTC PINK:MXSG) (“Mexus”…
Nilam Resources, Inc. Announces Aggressive Agenda to Enter Into the Health Industry through the Research and Development of Psilocybins and Functional Mushrooms in the Psychiatric Industry
SNOHOMISH, WA / ACCESSWIRE / November 1, 2021 / Nilam Resources, Inc. (OTC PINK:NILA) $NILA…
Commerce Resources Reports Saville Resources Intersects 1.00% Nb2O5 over 17.1 m, including 1.39% Nb2O5 over 5.1 m, in Drill Hole at the Mallard Prospect, Niobium Claim Group Property, Quebec
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Commerce Resources Corp. (TSXV:CCE)(FSE:D7H0)(OTCQX:CMRZF) (the “Company”…
Saville Resources Intersects 1.00% Nb2O5 over 17.1 m, including 1.39% Nb2O5 over 5.1 m, in Drill Hole at the Mallard Prospect, Niobium Claim Group Property, Quebec
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Saville Resources Inc. (TSXV:SRE)(FRA:S0J) (the “Company”…
Fission 3.0 Corp. and Traction Exploration Enter into ALois on Athabasca Properties
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Fission Uranium 3.0 (“Fission 3.0 Corp”…
Eco (Atlantic) Oil and Gas Ltd Announces Operational Update and Notice of AGM
TORONTO, ON / ACCESSWIRE / November 1, 2021 / Eco (Atlantic) Oil & Gas Ltd….
Ferguson PLC Announces Block listing Interim Review
BLOCK LISTING SIX MONTHLY RETURN WOKINGHAM, UK / ACCESSWIRE / November 1, 2021 / Date:…
The Future of Time is Synchronised and Vital to Business Success
‘A Matter of Time: The Hoptroff Annual Timing Review’ looks at the past, present and future of time,…
Forsta Partners with Lumoa to Deliver Powerful, AI-Driven Analytics To CX, EX and Market Research Professionals
Partnership will streamline open-ended feedback using artificial intelligence to drive better-informed decisions NEW YORK and…
Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca
ZUG, Switzerland, Nov. 01, 2021 (GLOBE NEWSWIRE) — Covis Pharma Group (“Covis”), a global specialty…
Verona Pharma Announces November 2021 Investor Conference Participation
LONDON and RALEIGH, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November
Press Release 01 November 2021 Immunicum to Participate in Multiple Upcoming Industry and Investor…
DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021
Montrouge, France, November 1, 2021 DBV Technologies to Highlight New Long-term Data from REALISE Trial…
Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to Approximately $102.0 Million
Saint-Herblain (France), November 1, 2021 – Valneva SE, a specialty vaccine company, announced today that…
Hyloris Announces FDA Acceptance of New Drug Application for Maxigesic® IV in Post-Operative Pain
Hyloris to receive $1 million milestone payment Maxigesic® IV has the potential to combat the…
Idorsia to advance cenerimod into Phase 3 development for treatment of patients with systemic lupus erythematosus
Ad hoc announcement pursuant to Art. 53 LR Cenerimod 4 mg showed clinically meaningful improvement…
Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021
Geneva, Switzerland, November 1, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical…
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and…